Physician
Internal Medicine
Dr. Stefano M. Bertozzi, MD
Stefano M. Bertozzi, MD works in the field of Internal Medicine. He attended University of California San Diego School of Medicine. University of California San Diego School of Medicine is ranked 17 in research and 19 in primary care medicine Stefano Bertozzi is a published doctor and has 61 publications published. The lastest was: 'Summary of track D: social science: research, policy and action.'
Publications
- An Automated Telephone Nutrition Support System for Spanish-Speaking Patients With Diabetes.
- Willingness-to-accept reductions in HIV risks: conditional economic incentives in Mexico.
- Evaluation of Large-Scale Combination HIV Prevention Programs: Essential Issues.
- Can cost studies improve the performance of donor-financed HIV treatment?
- Optimizing HIV treatment programs.
- The evolving HIV/AIDS response and the urgent tasks ahead.
- Severe respiratory disease concurrent with the circulation of H1N1 influenza.
- Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.
- Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks.
- Improving enrollment and utilization of the Oportunidades program in Mexico could increase its effectiveness.
- Herpes simplex virus type 2 among Mexican high school adolescents: prevalence and association with community characteristics.
- Variations in prenatal care quality for the rural poor in Mexico.
- Current priorities in health research funding and lack of impact on the number of child deaths per year.
- The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico.
- Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico.
- High prevalence of obesity among the poor in Mexico.
- A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population.
- [Outcome of pregnancy for immigrant women: a retrospective study].
- Adding the human dimension to economic analysis: why DALYs don''t tell the whole story.
- The impact of human immunodeficiency virus/AIDS.
- Assessing and alleviating the real impact of AIDS.
- [Prevalence of urinary incontinence and pelviperineal rehabilitation during the postpartum in a cohort of primipara and secondipara patients].
- Challenge of evaluating a national HIV prevention programme: the case of loveLife, South Africa.
- Combating HIV in Africa: a role for economic research.
- The art of public health: pneumococcal vaccine coverage in Mexico.
- Pandemic flu: from the front lines. Interviewed by Declan Butler.
- Redesigning the AIDS response for long-term impact.
- Post-emergency: providing effective, sustainable, life-long care to everyone with AIDS.
- Summary of track D: social science: research, policy and action.
- Obstacles to the optimal management of HIV infection/AIDS in Africa.
- Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models.
- Informing scale-up and resource allocation: the use of economic analysis.
- AIDS. Resource needs for HIV/AIDS.
- How much attention is needed towards men who sell sex to men for HIV prevention in India?
- Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project.
- HIV prevention cost-effectiveness: a systematic review.
- Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country.
- Improving access to treatment for HIV in sub-Saharan Africa.
- Treatment as prevention: translating efficacy trial results to population effectiveness.
- Re: This special issue of AIDS--a mix of recent economic analyses and commentary on how best to distill economic insights to improve HIV/AIDS policies and programmes.
- Combination HIV prevention.
- Male circumcision at different ages in Rwanda: a cost-effectiveness study.
- Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
- Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
- Scaling up HAART in Mexico. Response to Volkow et al.
- Stakeholders'' opinions and expectations of the Global Fund and their potential economic implications.
- The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.
- The Mexican HIV/AIDS surveillance system: 1986-2001.
- Evaluation of HIV prevention programmes: the case of Avahan.
- HIV prevention transformed: the new prevention research agenda.
- Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
- The economic impacts of HIV/AIDS on households and economies.
- Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context.
- Sex behaviour of men who have sex with men and risk of HIV in Andhra Pradesh, India.
- HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
- Estimating resource needs for HIV/AIDS health care services in low-income and middle-income countries.
- Resources for HIV/AIDS prevention and care.
- HIV prevention in Mexican schools: prospective randomised evaluation of intervention.
- Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
- Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico.
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
UCSF -
University of California San Diego School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Constance C. Wang, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. David J. Tauben, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evelyn S. Vinopal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher M. Mathews, MD |
|
|
Dr. Nancy K. Sugg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna S. Loge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irina L. Triska, MD |
|
|
Dr. Kathleen E. Volkman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lindee S. Tull, MD
This Doctor is OpenDoctor Recommended.
|